193P Translational, PK, PD, and immunophenotyping analyses of tuvusertib + niraparib in a phase Ib open-label multicenter dose-escalation study in patients with advanced solid tumors (DDRiver Solid Tumors 301)
| Autor: | Tolcher, A.W., Yap, T.A., Plummer, R., Sommerhalder, D., Rodon, J., Lagonera, M., Bergmann, P., Perez, V. Sanchez, Wohlfeil, N., Wang, D., Mukker, J. Kaur, Sessa, G., Manginelli, A., de Bono, J.S. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S292-S293 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|